Literature DB >> 17562828

Activities of daily living in frontotemporal dementia and Alzheimer disease.

E Mioshi1, C M Kipps, K Dawson, J Mitchell, A Graham, J R Hodges.   

Abstract

OBJECTIVE: To evaluate activities of daily living (ADLs) in three clinical variants of frontotemporal dementia and the relationship to cognitive dysfunction.
METHODS: Fifty-nine patients and caregivers participated in this cross-sectional study: behavioral variant frontotemporal dementia (bv-FTD, n = 15), progressive nonfluent aphasia (PNFA, n = 10), semantic dementia (n = 15), and Alzheimer disease (AD, n = 19). Caregivers were interviewed with the Disability Assessment for Dementia (DAD) to provide two outcome measures about ADLs: basic and instrumental ADLs (BADLs, IADL). In addition, patients were rated on the Clinical Dementia Rating Scale (CDR), and performance on cognitive measures (Addenbrooke's Cognitive Examination Revised [ACE-R]) was assessed.
RESULTS: On the DAD, the bv-FTD group was most affected (56% of normal), whereas PNFA and semantic dementia patients were least impaired (83% and 85%); AD was intermediate (76%). The opposite pattern was seen on the ACE-R, where PNFA and semantic dementia groups were most affected, and bv-FTD showed least impairment; AD was again intermediate. Scores on the DAD did not correlate with cognitive measures, CDR, or disease duration. We further analyzed which aspect of ADLs was most affected, and a unique pattern of deficits emerged for the bv-FTD group (initiation affected > planning > execution for BADLs).
CONCLUSION: Frontotemporal dementia has a devastating effect on activities of daily living, which is of considerable importance to caregivers and not captured by bedside cognitive tests.

Entities:  

Mesh:

Year:  2007        PMID: 17562828     DOI: 10.1212/01.wnl.0000264897.13722.53

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia.

Authors:  O Piguet; M Hornberger; B P Shelley; C M Kipps; J R Hodges
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

Review 2.  "All is not lost"-Rethinking the nature of memory and the self in dementia.

Authors:  Cherie Strikwerda-Brown; Matthew D Grilli; Jessica Andrews-Hanna; Muireann Irish
Journal:  Ageing Res Rev       Date:  2019-06-22       Impact factor: 10.895

3.  Executive Dysfunction and Behavioral Symptoms Are Associated with Deficits in Instrumental Activities of Daily Living in Frontotemporal Dementia.

Authors:  Negar Moheb; Mario F Mendez; Sarah A Kremen; Edmond Teng
Journal:  Dement Geriatr Cogn Disord       Date:  2017-01-20       Impact factor: 2.959

Review 4.  Quantitating severity and progression in primary progressive aphasia.

Authors:  Bradford C Dickerson
Journal:  J Mol Neurosci       Date:  2011-05-15       Impact factor: 3.444

Review 5.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

Review 6.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

7.  Deficits in Everyday Function Differ in AD and FTD.

Authors:  Lovingly Q Park; Danielle Harvey; Julene Johnson; Sarah T Farias
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Oct-Dec       Impact factor: 2.703

Review 8.  The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Authors:  Adam L Boxer; Michael Gold; Edward Huey; William T Hu; Howard Rosen; Joel Kramer; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; George Jackson; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven S Khachaturian; Margaret Sutherland; Susan Abushakra; Joseph Lewcock; Robert Farese; Robert O Kenet; Frank Laferla; Steve Perrin; Steve Whitaker; Lawrence Honig; Marsel M Mesulam; Brad Boeve; Murray Grossman; Bruce L Miller; Jeffrey L Cummings
Journal:  Alzheimers Dement       Date:  2012-10-10       Impact factor: 21.566

9.  Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS).

Authors:  Angela G Brega; Ann Reynolds; Rachael E Bennett; Maureen A Leehey; Lanee S Bounds; Jennifer B Cogswell; Randi J Hagerman; Paul J Hagerman; Jim Grigsby
Journal:  Int J Geriatr Psychiatry       Date:  2009-10       Impact factor: 3.485

10.  Estimating severity of illness and disability in Frontotemporal Dementia: Preliminary analysis of the Dementia Disability Rating (DDR).

Authors:  Chiadi U Onyike; Kelly L Sloane; Shawn F Smyth; Brian S Appleby; David M Blass; Peter V Rabins
Journal:  Acta Neuropsychol       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.